Please login to the form below
vaccines
This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.
MHRA to introduce new UK clinical trials framework
to meet the UK’s healthcare priorities’, such as cancer vaccines.
Latest news
-
Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
months to four years, compared to those who received three doses of the companies’ original vaccine. ... The safety and tolerability profile of the bivalent vaccine was similar to that of the original vaccine, the companies said.
-
GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
There are currently no licensed vaccines offering simultaneous protection against all five serogroups. ... vaccine candidate six months apart, compared to those receiving the Bexsero and Menveo regimen.
-
Merck reports positive results for Keytruda combination in malignant pleural mesothelioma
The drug was granted breakthrough therapy designation in the US in February, in combination with Merck and Moderna’s investigational personalised mRNA cancer vaccine, as an additional treatment for high-risk
-
BioNTech and Weizmann Institute to collaborate at company’s new mRNA centre in Israel
With the new facility, BioNTech plans to independently manufacture plasmid DNA, which is an important starting material for the manufacturing of mRNA-based vaccines and therapies, as well as cell therapies.
-
Pfizer/BioNTech submit FDA application for Omicron-adapted booster for young children
to four years, compared to those who received three doses of the companies’ original vaccine. ... Vaccine manufacturers have been focused on the development of variant specific boosters since the World Health Organization recommended that COVID-19
More from news
Approximately 279 fully matching, plus 1,621 partially matching documents found.
Latest Intelligence
-
The state of pharma customer experience
The scale of change that, for example, Moderna faced saw the company’s revenues skyrocket from $803m in 2020 to $18.5bn in 2021, thanks of course to its Spikevax vaccine.
-
Mental health post-COVID-19: what are the consequences and lessons learned for healthcare?
The pandemic highlighted the outdated process for vaccine approvals, the need for innovations in information-sharing and the importance of coordinating clinical trials and cohort studies.
-
A new age of innovation in healthcare
It is also important to ensure that the short-term reputational gains from creating and manufacturing COVID-19 vaccines is not lost over time. ... Everyone will refer back to the time when various pharmaceutical companies came together to focus on
-
Unlocking the potential of data sharing
approval, in record time, of the first COVID-19 vaccine.
-
Influenza – the risk to vulnerable populations
In the US, the Advisory Committee on Immunization Practices acknowledged that there was evidence of benefit favouring each of the enhanced influenza vaccines over standard dose vaccines: Flublok Quadrivalent (Influenza Vaccine) ... I want to stress here
More from intelligence
Approximately 6 fully matching, plus 159 partially matching documents found.
Latest appointments
-
ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
In this role, he oversaw all media relations for the UK’s COVID-19 vaccination programme, providing strategic advice to Vaccines Minister Nadhim Zahawi and Health and Social Care Secretary Matt
-
Virtual agency The Difference Collective makes new hires to senior team
Hornby has led communications for the UK government’s Vaccine Taskforce and previously led media and communications for GlaxoSmithKline.
-
Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm
Over the course of his most recent stint at Merck, the company has achieved over 100 regulatory approvals for its medicines and vaccines globally. ... As a result of Roger’s hands-on and inspirational leadership, MRL is well positioned to bring forward
-
Evoke KYNE promotes Dante DelVecchio to senior VP
In his new role, he will become a member of the firm’s senior management team, and will continue to oversee key client engagements in infectious diseases, vaccines and immuno-oncology.
-
New hires at Bayer, Eisai and Accord Healthcare
Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
More from appointments
Approximately 5 fully matching, plus 66 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
25. 5. It's bridging the gender data gap. As we mentioned in our recent blog ‘Why the COVID-19 vaccines are a women’s health issue’, there is a concerning
-
Video: Strategic engagement case study
Supporting the launch of a global vaccine with a programme of market research and strategic insights. ... Our client, who had built a new business unit for a vaccine product, needed a full programme of research to support and enhance their product’s pre
-
Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence
The challenge was developing robust guidance in a timely manner with a goal of providing clarity on vaccine timing, efficacy, and safety, to support healthcare professionals and their patients.
-
Celebrating award-winning patient-centricity
ZPB Associates for their Vaccine Facts Website.
-
There's power in collaboration
Just look at the success of the Covid-19 vaccine development… from the collaboration between AstraZeneca, Oxford University and it’s Vaccitech company to the partnership between BioNTech, Fosun Pharma and ... Pfizer, the fastest development of a
More from PMHub
Approximately 17 fully matching, plus 105 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- FDA external report recommends actions to address US opioid crisis
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Congress is in session – how companies are boosting their impact and engagement
- AstraZeneca announces major expansion of Canadian research footprint
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
